JANX Janux Therapeutics, Inc.
Nasdaq · SEC CIK 1817713 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.06M 11 sales by 7 insiders
- Filings on record
- 128 since 2021-09-09, latest 2026-07-31 20:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Meyer Andrew Hollman | Chief Business Off | — | $736.7K |
| Campbell David Alan | Pres, CEO, Dir | — | $110.8K |
| Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | — | $56.9K |
| Dobek Maria | VP, Accounting | — | $49.0K |
| McIver Zachariah | Chief Medical Off | — | $37.3K |
| DiRaimondo Thomas | CSO | — | $34.4K |
| Winter Charles M. | Chief Technical Off | — | $33.0K |
| Go William | Chief Medical Off | — | — |
| Simson Jake | Dir | — | — |
| Hernday Natasha | Dir | — | — |
Transactions 113
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-04 | 2024-02-29 | JANX | Gujrathi Sheila | Dir | J - Other | $0.00 | +2,986 | 108.0K | +3% | $0 | |
| 2024-03-04 | 2024-02-29 | JANX | Avalon Ventures XI, L.P. | 10% | J - Other | $0.00 | -438.7K | 3.95M | -10% | $0 | |
| MI | 2024-03-04 | 2024-02-29 | JANX | Avalon Ventures XI, L.P. | 10% | J - Other | $0.00 | -532.9K | 4.03M | -12% | $0 |
| I | 2023-11-15 | 2023-11-13 | JANX | Lichter Jay | Dir, 10% | P - Purchase | $5.87 | +849.9K | 849.9K | New | +$4.99M |
| I | 2023-11-15 | 2023-11-13 | JANX | Reardon Tighe | Acting CFO, 10% | P - Purchase | $5.87 | +849.9K | 849.9K | New | +$4.99M |
| I | 2023-11-13 | 2023-11-13 | JANX | Avalon Ventures XI, L.P. | 10% | P - Purchase | $5.87 | +849.9K | 849.9K | New | +$4.99M |
| DI | 2023-07-21 | 2023-07-19 | JANX | RA Capital Nexus Fund II, L.P. | Dir | P - Purchase | $12.46 | +495.0K | 8.12M | +6% | +$6.17M |
| MI | 2021-12-30 | 2021-12-29 | JANX | OrbiMed Genesis GP LLC | Dir | S - Sale | $20.30 | -40.4K | 231.1K | -15% | -$820.1K |
| MI | 2021-12-30 | 2021-12-29 | JANX | Thompson Peter A. | Dir | S - Sale | $20.30 | -40.4K | 2.26M | -2% | -$820.1K |
| MI | 2021-12-23 | 2021-12-21 | JANX | OrbiMed Genesis GP LLC | Dir | S - Sale | $19.00 | -119.4K | 234.8K | -34% | -$2.27M |
| MI | 2021-12-23 | 2021-12-21 | JANX | Thompson Peter A. | Dir | S - Sale | $19.00 | -119.4K | 234.8K | -34% | -$2.27M |
| MI | 2021-12-17 | 2021-12-16 | JANX | OrbiMed Genesis GP LLC | Dir | S - Sale | $19.07 | -393.3K | 245.9K | -62% | -$7.50M |
| MI | 2021-12-17 | 2021-12-16 | JANX | Thompson Peter A. | Dir | S - Sale | $19.07 | -393.3K | 2.40M | -14% | -$7.50M |
Purchase Sale Sale after option exercise All abbreviations